Amanote Research
Register
Sign In
P2.12-01 Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1377
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
J. Kang
K.H. Lee
D. Kim
S. Kim
H.R. Kim
J. Kim
J.H. Choi
H.J. An
J. Kim
J.S. Jang
B. Kim
H.T. Kim
Publisher
Elsevier BV